Calidi Biotherapeutics shares are trading lower after the company announced the exercise of warrants for $2.1 million in gross proceeds.
Portfolio Pulse from Benzinga Newsdesk
Calidi Biotherapeutics shares are trading lower after the company announced the exercise of warrants for $2.1 million in gross proceeds.
May 31, 2024 | 5:36 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Calidi Biotherapeutics shares are trading lower after the company announced the exercise of warrants for $2.1 million in gross proceeds.
The exercise of warrants typically leads to an increase in the number of shares outstanding, which can dilute the value of existing shares. This is likely why the stock is trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100